| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.083 | 0.2 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.077 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |